Literatur
- 1
Bennedbaek F N, Hegedus L.
Management of the solitary thyroid nodules: results of a North American Survey.
J Clin Endocrinol Metab.
2000;
85
2493-2498
- 2
Farahati J. et al .
Changing Trends of Incidence and Prognosis of Thyroid Carcinoma in Lower Franconia,
Germany, from 1981-1995.
Thyroid.
2004;
14
141-147
- 3
Hegedus L.
Clinical practice: The thyroid nodule.
N Engl J Med.
2004;
351
1764-1771
- 4
Hölzer S, Reiners C, Mann K. et al. US and German Thyroid Cancer Group .
Patterns of care for patients with primary differentiated carcinoma of the thyroid
gland treated in Germany during 1996.
Cancer.
2000;
89
192-201
- 5
Hundahl S A, Fleming I D, Fremgen A G. et al .
A national cancer data base report on 53856 cases of thyroid carcinoma Treated in
the US 1985-1995.
Cancer.
1998;
83
1238-2648
- 6
Iacobone M, Niccoli-Sire P, Sebag F, De Micco C, Henry J F.
Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis
of 66 operated patients with elevated serum calcitonin levels.
World J Surg.
2002;
26
886-890
- 7
Kahaly G J, Dietlein M.
Cost Estimation of Thyroid Disorders in Germany.
Thyroid.
2002;
12
909-914
- 8
Karanikas G. et al .
Frequency and relevance of elevated calcitonin levels in patients with neoplastic
and nonneoplastic thyroid disease and healthy subjects.
Journal of Clinical Endocrinology & Metabolism.
2004;
89
515-519
- 9
Kaserer K. et al .
C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened
for serum calcitonin.
Am J Surg Pathol.
1998;
22
722-728
- 10
Lips C J, Hoppener J W, Thijssen J H.
Medullary thyroid carcinoma: role of genetic testing and calcitonin measurement.
Ann Clin Biochem.
2001;
38
168-179
- 11
Mann K.
Diagnosis and therapy of differentiated thyroid gland carcinomas.
Internist.
2002;
43
174-185
- 12
Papini E. et al .
Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound
and color-doppler features.
J Clin Endocrinol Metab.
2002;
87
1941-1946
- 13
Paschke R, Reiners C, Führer D, Schmid K W, Dralle H, Brabant G.
Empfehlungen und offene Fragen in der Diagnostik und Therapie von Schilddrüsenknoten.
Dtsch Med Wochenschr.
2005;
130
1831-1836
- 14
Reiners C, Wegschneider K, Schicha H. et al .
Prevalence of thyroid disorders in the working population of Germany: Ultrasonography
screening in 96 278 unselected employees.
Thyroid.
2004;
14
926-932
- 15
Reiners C, Geling M, Luster M, Farahati J, Mäder U.
Epidemiologie des Schilddrüsenkarzinoms.
Onkologe.
2005;
11
11-19
- 16
Ron E. et al .
Thyroid Cancer after exposure to external radiation: a pooled analyses of seven studies.
Rad Research.
1995;
141
259-277
- 17
Ross D S.
Editorial: Nonpalpable Thyroid Nodules-Managing an Epidemic.
J Clin Endocrinol Metabolism.
2002;
87
1938-1940
- 18
Saller B, Moeller L, Görges R, Janssen O E, Mann K.
Role of Conventional Ultrasound and Color Doppler Sonography in the Diagnosis of Medullary
Thyroid Carcinoma.
Exp Clin Endocrinol Diabetes.
2002;
110
403-407
- 19
Scriba P C.
Schilddrüsenknoten: Noch mehr Fragen.
Dtsch Med Wochenschr.
2005;
130
1809
- 20
Surks M I. et al .
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.
JAMA.
2004;
14
228-238
- 21
Scheuba C. et al .
Prevalence of C-cell hyperplasia in patients with normal basal and pentagastrin-stimulated
calcitonin.
Thyroid.
2000;
10
413-416
- 22
Uwaifo G I. et al .
A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin
assays in the screening of patients with thyroid nodules for neoplasia.
J Endocrinol Invest.
2001;
24
361-369
- 23
Vitale G. et al .
Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma:
omeprazole vs pentagastrin.
Clin Chem.
2002;
48
1505-1510
Prof. Dr. med. B. Braun,
Dr W. Blank
Medizinische Klinik, Klinikum am Steinenberg
Steinenbergstr. 31
72764 Reutlingen
Email: braun_b@kreiskliniken-reutlingen.de
